HRTX Heron Therapeutics, Inc.
Fundamentals / CIK 0000818033 / USDHeron Therapeutics, Inc. reported $148.2M in revenue and a net loss of $21.56M for the trailing twelve months ended September 30, 2026 (down 7.8% year over year), with a 71.5% gross margin and a -5.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HRTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$148.2M -7.8% YoY
-
Operating Income TTM-$8.44M -5.7% margin
-
Net Income TTM-$21.56M -14.5% net margin
-
Diluted EPS TTM-$0.11 Split-adjusted
-
Free Cash Flow TTM-$14.36M -9.7% FCF margin
-
Cash & ST Investments Sep 30, 2026$23.45M Total debt: $5.72M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $154.9M | $144.3M | $127.0M | $107.7M | $86.35M | $88.64M | $146.0M | $77.47M | $30.77M | $1.28M |
| Cost of Revenue | $41.35M | $38.65M | $65.11M | $54.87M | $46.02M | $36.19M | $61.62M | $27.51M | $4.59M | $35K |
| Gross Profit | $113.6M | $105.6M | $61.94M | $52.80M | $40.33M | $52.45M | $84.35M | $49.96M | $26.18M | $1.24M |
| Research & Development | $12.43M | $16.68M | $39.13M | $82.70M | $130.8M | $174.5M | $167.4M | $140.0M | $138.6M | $103.1M |
| Selling, General & Admin | $103.7M | $100.5M | $133.4M | $144.8M | $127.3M | $106.1M | $127.7M | $93.87M | $82.16M | $69.03M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $261.4M | $225.3M | $172.2M |
| Operating Income | -$2.54M | -$11.53M | -$110.6M | -$174.7M | -$217.8M | -$228.2M | -$210.7M | -$183.9M | -$194.6M | -$170.9M |
| EBITDA | -$224K | -$9.04M | -$107.7M | -$171.8M | -$214.8M | -$225.3M | -$208.7M | -$182.4M | -$193.0M | -$169.8M |
| Interest Income | $1.95M | $3.55M | $3.36M | $1.64M | $433K | $3.63M | $7.26M | $5.96M | $1.05M | $445K |
| Interest Expense | $9.61M | $6.03M | $3.87M | $2.47M | $2.41M | $1.90M | $1.47M | $2.67M | $3.94M | $2.66M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20.20M | -$13.58M | -$110.6M | -$182.0M | -$220.7M | -$227.3M | -$204.7M | -$178.8M | -$197.5M | -$173.1M |
| Basic EPS | -$0.12 | -$0.09 | -$0.80 | -$1.67 | -$2.24 | -$2.50 | -$2.50 | -$2.44 | -$3.65 | -$4.56 |
| Diluted EPS | -$0.12 | -$0.09 | -$0.80 | -$1.67 | -$2.24 | -$2.50 | -$2.50 | -$2.44 | -$3.65 | -$4.56 |
| Basic Shares Outstanding | 166.7M | 152.4M | 138.1M | 108.9M | 98.5K | 90.8M | 81.8M | 73.2M | 54.0M | 37.9M |
| Diluted Shares Outstanding | 166.7M | 152.4M | 138.1M | 108.9M | 98.5K | 90.8M | 81.8M | 73.2M | 54.0M | 37.9M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.25M | $37.67M | $34.71M | $40.59M | $38.21M | $37.20M | $38.90M | $40.78M |
| Cost of Revenue | $8.96M | $11.57M | $10.64M | $11.12M | $11.91M | $9.86M | $8.46M | $10.23M |
| Gross Profit | $26.29M | $26.09M | $24.07M | $29.47M | $26.30M | $27.34M | $30.45M | $30.55M |
| Research & Development | $3.10M | $2.70M | $2.38M | $3.75M | $3.47M | $2.93M | $2.28M | $3.18M |
| Selling, General & Admin | $24.86M | $25.44M | $26.45M | $25.68M | $26.92M | $26.05M | $25.01M | $23.20M |
| Operating Income | -$1.67M | -$2.04M | -$4.76M | $38K | -$4.09M | -$1.64M | $3.15M | $4.17M |
| EBITDA | -$1.28M | -$1.59M | -$4.24M | $575K | -$3.48M | -$1.03M | $3.71M | $4.75M |
| Net Income | -$5.01M | -$5.49M | -$8.11M | -$2.95M | -$17.50M | -$2.38M | $2.63M | $3.66M |
| Basic EPS | -$0.03 | -$0.03 | -$0.04 | -- | -$0.10 | -$0.02 | $0.02 | -- |
| Diluted EPS | -$0.03 | -$0.03 | -$0.04 | -- | -$0.10 | -$0.02 | $0.01 | -- |
| Basic Shares Outstanding | 190.9M | 190.3M | 189.6M | -- | 170.3M | 154.0M | 153.5M | -- |
| Diluted Shares Outstanding | 190.9M | 190.3M | 189.6M | -- | 170.3M | 154.0M | 196.9M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $28.65M | $25.80M | $28.68M | $15.36M | $90.54M | $105.1M | $71.90M | $31.84M | $144.6M | $13.41M |
| Short-Term Investments | $17.98M | $33.48M | $51.73M | $69.49M | $67.04M | $103.4M | $319.1M | $300.5M | -- | -- |
| Cash & Short-Term Investments | $46.60M | $59.30M | $80.40M | $84.90M | $157.6M | $208.5M | $391.0M | $332.4M | $172.4M | $51.10M |
| Accounts Receivable, Net | $89.59M | $78.88M | $60.14M | $52.05M | $35.50M | $41.85M | $39.88M | $64.65M | $41.87M | $1.96M |
| Inventory | $92.75M | $53.16M | $42.11M | $54.57M | $48.38M | $41.91M | $24.97M | $39.03M | $10.11M | $5.34M |
| Total Current Assets | $238.1M | $209.0M | $188.8M | $205.4M | $254.4M | $314.2M | $479.1M | $447.2M | $228.1M | $62.14M |
| Property, Plant & Equipment, Net | $12.40M | $14.86M | $20.17M | $22.16M | $23.73M | $22.74M | $19.62M | $14.68M | $5.98M | $5.08M |
| Other Non-Current Assets | $5.41M | $6.48M | $8.13M | $15.71M | $17.72M | $346K | $346K | $254K | $263K | $263K |
| Total Non-Current Assets | $17.81M | $24.13M | $33.73M | $45.52M | $51.28M | $39.36M | $33.72M | $14.93M | $6.24M | $5.34M |
| Total Assets | $255.9M | $233.1M | $222.5M | $251.0M | $305.7M | $353.6M | $512.8M | $462.2M | $234.3M | $67.48M |
| Accounts Payable | $8.99M | $11.71M | $3.24M | $3.23M | $3.80M | $525K | $2.76M | $16.86M | $18.77M | $6.81M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | $2.76M | $1.10M |
| Total Current Liabilities | $96.10M | $91.46M | $79.69M | $82.36M | $71.06M | $102.5M | $96.70M | $92.02M | $103.2M | $38.73M |
| Other Non-Current Liabilities | $4.81M | $615K | $241K | $241K | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $145.4M | $175.3M | $176.8M | $155.0M | $157.1M | $14.56M | $12.24M | $0 | $0 | $50.00M |
| Total Liabilities | $241.5M | $266.8M | $256.5M | $237.4M | $228.1M | $117.1M | $108.9M | $92.02M | $103.2M | $88.73M |
| Total Debt (incl. Leases) | -- | $3.04M | $5.88M | $8.19M | $10.41M | $17.56M | $14.17M | -- | -- | -- |
| Common Stock | $1.88M | $1.52M | $1.50M | $1.19M | $1.02M | $913K | $903K | $782K | $646K | $394K |
| Retained Earnings | -$1.94B | -$1.92B | -$1.91B | -$1.80B | -$1.61B | -$1.39B | -$1.17B | -$960.7M | -$783.5M | -$586.0M |
| Accumulated Other Comp. Income | $4.0K | $13K | $13K | -$19K | -$6.0K | $257K | $85K | -$87K | -$10K | -$17K |
| Total Stockholders' Equity | $14.33M | -$33.65M | -$33.97M | $13.57M | $77.57M | $236.5M | $403.8M | $370.2M | $131.1M | -$21.25M |
| Total Equity | $14.33M | -$33.65M | -$33.97M | $13.57M | $77.57M | $236.5M | $403.8M | $370.2M | $131.1M | -$21.25M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $11.60M | $20.72M | $26.12M | $28.65M | $43.07M | $16.52M | $19.27M | $25.80M |
| Short-Term Investments | $11.85M | $21.94M | $18.67M | $17.98M | $12.42M | $24.12M | $31.41M | $33.48M |
| Cash & Short-Term Investments | $23.40M | $42.70M | $44.80M | $46.60M | $55.50M | $40.60M | $50.70M | $59.30M |
| Accounts Receivable, Net | $86.73M | $89.57M | $83.69M | $89.59M | $81.05M | $79.93M | $78.74M | $78.88M |
| Inventory | $91.30M | $90.58M | $92.54M | $92.75M | $70.03M | $72.97M | $56.93M | $53.16M |
| Total Current Assets | $209.1M | $229.8M | $229.0M | $238.1M | $229.4M | $210.9M | $212.8M | $209.0M |
| Property, Plant & Equipment, Net | $11.08M | $11.81M | $12.03M | $12.40M | $12.96M | $13.68M | $14.54M | $14.86M |
| Other Non-Current Assets | $4.81M | $5.01M | $5.21M | $5.41M | $5.88M | $6.08M | $6.28M | $6.48M |
| Total Non-Current Assets | $21.34M | $22.42M | $17.23M | $17.81M | $19.55M | $21.17M | $22.91M | $24.13M |
| Total Assets | $230.4M | $252.3M | $246.2M | $255.9M | $248.9M | $232.1M | $235.8M | $233.1M |
| Accounts Payable | $8.38M | $11.64M | $8.97M | $8.99M | $12.02M | $12.04M | $12.33M | $11.71M |
| Total Current Liabilities | $89.85M | $92.14M | $90.52M | $96.10M | $89.71M | $258.6M | $88.56M | $91.46M |
| Other Non-Current Liabilities | $4.31M | $5.05M | $4.93M | $4.81M | $4.69M | $747K | $682K | $615K |
| Total Non-Current Liabilities | $135.7M | $153.2M | $146.6M | $145.4M | $144.4M | $747K | $175.6M | $175.3M |
| Total Liabilities | $225.5M | $245.4M | $237.1M | $241.5M | $234.1M | $259.3M | $264.2M | $266.8M |
| Total Debt (incl. Leases) | $5.72M | $5.70M | -- | -- | $780K | $1.54M | $2.29M | $3.04M |
| Common Stock | $1.90M | $1.90M | $1.89M | $1.88M | $1.83M | $1.53M | $1.52M | $1.52M |
| Retained Earnings | -$1.96B | -$1.95B | -$1.95B | -$1.94B | -$1.94B | -$1.92B | -$1.92B | -$1.92B |
| Accumulated Other Comp. Income | -$7.0K | -$6.0K | -$6.0K | $4.0K | $0 | -$1.0K | $1.0K | $13K |
| Total Stockholders' Equity | $4.92M | $6.91M | $9.14M | $14.33M | $14.88M | -$27.26M | -$28.45M | -$33.65M |
| Total Equity | $4.92M | $6.91M | $9.14M | $14.33M | $14.88M | -$27.26M | -$28.45M | -$33.65M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.20M | -$13.58M | -$110.6M | -$182.0M | -$220.7M | -$227.3M | -$204.7M | -$178.8M | -$197.5M | -$173.1M |
| Depreciation & Amortization | $2.31M | $2.49M | $2.90M | $2.89M | $3.02M | $2.85M | $2.04M | $1.51M | $1.53M | $1.10M |
| Stock-Based Compensation | $10.34M | $12.96M | $32.85M | $42.98M | $46.85M | $50.22M | $51.41M | $33.37M | $30.54M | $25.96M |
| Change in Receivables | -$10.71M | -$18.74M | -$8.09M | -$16.55M | $6.35M | -$1.97M | $24.77M | -$22.78M | -$39.91M | -$1.96M |
| Change in Inventory | -$31.05M | -$11.05M | $12.46M | -$6.19M | -$6.48M | -$16.94M | $14.06M | -$29.12M | -$4.77M | -$5.34M |
| Change in Payables | -$2.71M | $8.47M | $15K | -$578K | $3.28M | -$2.23M | -$14.11M | -$1.91M | $11.96M | $3.51M |
| Operating Cash Flow | -$27.59M | -$22.53M | -$58.79M | -$146.9M | -$203.4M | -$184.8M | -$124.6M | -$191.8M | -$170.3M | -$134.1M |
| Capital Expenditure | -$317K | -$1.71M | -$1.54M | -$1.82M | -$3.02M | -$6.81M | -$7.15M | -$9.17M | -$2.55M | -$3.13M |
| Free Cash Flow | -$27.91M | -$24.23M | -$60.33M | -$148.7M | -$206.4M | -$191.6M | -$131.7M | -$201.0M | -$172.9M | -$137.2M |
| Purchases of Investments | -$50.79M | -$103.1M | -$87.66M | -$145.7M | -$129.2M | -$134.0M | -$477.0M | -$497.1M | -$121.6M | -- |
| Investing Cash Flow | $16.01M | $18.71M | $18.00M | -$3.32M | $32.73M | $209.0M | -$21.78M | -$278.6M | $7.74M | $14.88M |
| Common Stock Issued | $18.31M | -- | $29.75M | $75.14M | -- | -- | $162.2M | $363.1M | $306.3M | -- |
| Financing Cash Flow | $14.43M | $940K | $54.11M | $75.06M | $156.0M | $9.11M | $186.4M | $357.6M | $293.7M | $57.45M |
| Net Change in Cash | $2.85M | -$2.88M | $13.31M | -$75.18M | -$14.60M | $33.24M | $40.06M | -$112.7M | $131.2M | -$61.77M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$5.01M | -$5.49M | -$8.11M | -$2.95M | -$17.50M | -$2.38M | $2.63M | $3.66M |
| Depreciation & Amortization | $391K | $452K | $529K | $537K | $615K | $611K | $551K | $581K |
| Stock-Based Compensation | $3.08M | $3.18M | $2.98M | $2.18M | $2.85M | $2.80M | $2.51M | $2.29M |
| Change in Receivables | $2.84M | -$5.88M | $5.89M | -$8.54M | -$1.12M | -$1.20M | $145K | -$11.84M |
| Change in Inventory | -$735K | -$683K | -$169K | -$14.19M | $2.94M | -$16.03M | -$3.77M | -$7.21M |
| Change in Payables | -$3.16M | $2.57M | -$24K | -$3.02M | -$20K | -$296K | $624K | $1.52M |
| Operating Cash Flow | -$794K | -$2.21M | -$1.54M | -$9.18M | $1.33M | -$10.87M | -$8.87M | -$11.78M |
| Capital Expenditure | -$102K | -$138K | -$391K | $0 | $0 | -$208K | -$109K | -- |
| Free Cash Flow | -$896K | -$2.35M | -$1.93M | -$9.18M | $1.33M | -$11.08M | -$8.98M | -- |
| Purchases of Investments | -$6.04M | -$14.72M | -$13.14M | -$12.57M | -$6.13M | -$9.19M | -$22.90M | -$12.34M |
| Investing Cash Flow | $10.09M | -$3.27M | -$939K | -$5.46M | $11.86M | $7.33M | $2.27M | $11.42M |
| Financing Cash Flow | -$18.43M | $82K | -$51K | $219K | $13.36M | $781K | $64K | $423K |
| Net Change in Cash | -$9.13M | -$5.40M | -$2.53M | -$14.42M | $26.55M | -$2.75M | -$6.53M | $61K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | 49.0% | 46.7% | 59.2% | 57.8% | 64.5% | 85.1% | 97.3% |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% |
| Net Profit Margin | -13.0% | -9.4% | -87.0% | -169.1% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% |
| Return on Equity (ROE) | -140.9% | -- | -- | -1341.2% | -284.5% | -96.1% | -50.7% | -48.3% | -150.6% | -- |
| Return on Assets (ROA) | -7.9% | -5.8% | -49.7% | -72.5% | -72.2% | -64.3% | -39.9% | -38.7% | -84.3% | -256.6% |
| Current Ratio | 2.48x | 2.29x | 2.37x | 2.49x | 3.58x | 3.07x | 4.95x | 4.86x | 2.21x | 1.60x |
| Quick Ratio | 1.51x | 1.70x | 1.84x | 1.83x | 2.90x | 2.66x | 4.70x | 4.44x | 2.11x | 1.47x |
| Debt to Equity | -- | -- | -- | 0.60x | 0.13x | 0.07x | 0.04x | -- | -- | -- |
| Revenue Growth (YoY) | +7.4% | +13.6% | +18.0% | +24.7% | -2.6% | -39.3% | +88.4% | +151.8% | +2305.6% | -- |
| Gross Profit Growth (YoY) | +7.5% | +70.6% | +17.3% | +30.9% | -23.1% | -37.8% | +68.8% | +90.8% | +2004.4% | -- |
| 5Y Revenue / Share Growth | -4.8% | -47.0% | -13.1% | +73.7% | +2599993.2% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.5% | 70.1% | 71.1% | 73.3% | 73.9% | 74.6% | 74.0% | 73.2% |
| Operating Margin | -5.7% | -7.2% | -6.9% | -1.6% | 1.0% | 0.8% | -2.4% | -8.0% |
| Net Profit Margin | -14.5% | -22.5% | -20.5% | -13.0% | -8.8% | -0.6% | -5.2% | -9.4% |
| Return on Equity (ROE) | -438.6% | -492.9% | -338.6% | -140.9% | -91.2% | -- | -- | -- |
| Return on Assets (ROA) | -9.4% | -13.5% | -12.6% | -7.9% | -5.5% | -0.4% | -3.3% | -5.8% |
| Current Ratio | 2.33x | 2.49x | 2.53x | 2.48x | 2.56x | 0.82x | 2.40x | 2.29x |
| Quick Ratio | 1.31x | 1.51x | 1.51x | 1.51x | 1.78x | 0.53x | 1.76x | 1.70x |
| Debt to Equity | 1.16x | 0.83x | -- | -- | 0.05x | -- | -- | -- |
| Revenue Growth (YoY) | -7.8% | +1.3% | -10.8% | -0.5% | +16.5% | +3.3% | +12.2% | +19.1% |
| Gross Profit Growth (YoY) | 0.0% | -4.6% | -20.9% | -3.5% | +12.6% | +7.2% | +16.1% | +25.5% |
| Operating Income Growth (YoY) | -- | -- | -251.1% | -99.1% | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -407.8% | -180.6% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -300.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -159.7% | -- | -- | -- | -60.5% | -- | -- | -579.8% |
| Free Cash Flow Growth (YoY) | -167.3% | -- | -- | -- | -- | -- | -- | -- |